Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease

References

• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• WedzichaJABanerjiDChapmanKRIndacaterol-glycopyrronium versus salmeterol-fluticasone for COPDN Engl J Med2016374232222223427181606
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMAAlbertRKPrevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guidelineEur Respir J2017503160226528889106
   PubMed Web of Science ®Google Scholar
• MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohortChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• DonaldsonGCWedzichaJAThe causes and consequences of seasonal variation in COPD exacerbationsInt J Chron Obstruct Pulmon Dis201491101111025336941
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLAgustiAHeterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposalLancet Respir Med20153972973426165134
   PubMed Web of Science ®Google Scholar
• van GeffenWHSlebosDJKerstjensHAHyperinflation in COPD exacerbationsLancet Respir Med2015312e43e4426679031
   PubMed Web of Science ®Google Scholar
• MooreAJSolerRSCettiEJSniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPDRespir Med201010491319132520399631
   PubMed Web of Science ®Google Scholar
• CasanovaCCoteCde TorresJPInspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005171659159715591470
   PubMed Web of Science ®Google Scholar
• O’DonnellDEElbehairyAFWebbKANederJACanadian Respiratory Research NetworkThe link between reduced inspiratory capacity and exercise intolerance in chronic obstructive pulmonary diseaseAnn Am Thorac Soc201714Suppl 1S30S3928398073
   PubMed Web of Science ®Google Scholar
• MahlerDAO’DonnellDERecent advances in dyspneaChest2015147123224125560861
   PubMed Web of Science ®Google Scholar
• CooperCBThe connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and functionAm J Med200611910 Suppl 1213116996896
   PubMed Web of Science ®Google Scholar
• RossiAAisanovZAvdeevSMechanisms, assessment and therapeutic implications of lung hyperinflation in COPDRespir Med2015109778580225892293
   PubMed Web of Science ®Google Scholar
• O’DonnellDELavenezianaPThe clinical importance of dynamic lung hyperinflation in COPDCOPD20063421923217361503
   PubMedGoogle Scholar
• O’DonnellDEHyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary diseaseProc Am Thorac Soc20063218018416565429
   PubMedGoogle Scholar
• LangerDCiavagliaCENederJAWebbKAO’DonnellDELung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatmentExpert Rev Respir Med20148673174925159007
   PubMed Web of Science ®Google Scholar
• GuenetteJAWebbKAO’DonnellDEDoes dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?Eur Respir J201240232232922183485
   PubMed Web of Science ®Google Scholar
• ParkerCMVoducNAaronSDWebbKAO’DonnellDEPhysiological changes during symptom recovery from moderate exacerbations of COPDEur Respir J200526342042816135722
   PubMed Web of Science ®Google Scholar
• StevensonNJWalkerPPCostelloRWCalverleyPMLung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172121510151616166620
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVATS/ERS Task ForceStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• KoFWChanKPHuiDSAcute exacerbation of COPDRespirology20162171152116527028990
   PubMed Web of Science ®Google Scholar
• HawkinsPEAlamJMcDonnellTJKellyEDefining exacerbations in chronic obstructive pulmonary diseaseExpert Rev Respir Med20159327728626013261
   PubMed Web of Science ®Google Scholar
• WedzichaJASinghRMackayAJAcute COPD exacerbationsClin Chest Med201435115716324507843
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsSusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSEXACT-PRO Study GroupStandardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diaryAm J Respir Crit Care Med2011183332332920813886
   PubMed Web of Science ®Google Scholar
• van GeffenWHDoumaWRSlebosDJKerstjensHABronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPDCochrane Database Syst Rev20168CD011826
   Google Scholar
• BathoornEGroenhofFHendrixRReal-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary careInt J Chron Obstruct Pulmon Dis20171228529028144133
   PubMed Web of Science ®Google Scholar
• BrillSEWedzichaJAOxygen therapy in acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis201491241125225404854
   PubMed Web of Science ®Google Scholar
• van GeffenWHBruinsMKerstjensHADiagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot studyJ Breath Res201610303600127310311
   PubMed Web of Science ®Google Scholar
• GelbAFGutierrezCAWeismanIMNewsomRTaylorCFZamelNSimplified detection of dynamic hyperinflationChest200412661855186015596684
   PubMed Web of Science ®Google Scholar
• KloosterKten HackenNHHartmanJESciurbaFCKerstjensHASlebosDJDetermining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary diseaseRespiration201590430631326352833
   PubMed Web of Science ®Google Scholar
• O’DonnellDECasaburiRFrithPEffects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPDEur Respir J2017494160134828424359
   PubMed Web of Science ®Google Scholar
• MahlerDAKerstjensHADonohueJFBuhlRLawrenceDAltmanPIndacaterol vs tiotropium in COPD patients classified as GOLD A and BRespir Med201510981031103926094050
   PubMed Web of Science ®Google Scholar
• KerstjensHADesleeGDahlRThe impact of treatment with indacaterol in patients with COPD: a post-hoc analysis according to GOLD 2011 categories A to DPulm Pharmacol Ther20153210110825743376
   PubMed Web of Science ®Google Scholar
• PowrieDJWilkinsonTMDonaldsonGCEffect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPDEur Respir J200730347247817504798
   PubMed Web of Science ®Google Scholar
• O’DonnellDEFlügeTGerkenFEffects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPDEur Respir J200423683284015218994
   PubMed Web of Science ®Google Scholar
• CasaburiRMaltaisFPorszaszJ205.440 InvestigatorsEffects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary diseaseAnn Am Thorac Soc20141191351136125289942
   PubMedGoogle Scholar
• WedzichaJAAgustiADonaldsonGChuecosFLamarcaRGarcia GilEEffect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: a pooled analysis of five Phase III, randomized, placebo-controlled studiesCOPD201613666967627159613
   PubMedGoogle Scholar
• WilkinsonTMDonaldsonGCHurstJRSeemungalTAWedzichaJAEarly therapy improves outcomes of exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004169121298130314990395
   PubMed Web of Science ®Google Scholar
• van GeffenWHKerstjensHAMSlebosDJEmerging bronchoscopic treatments for chronic obstructive pulmonary diseasePharmacol Ther20171799610128527920
   PubMed Web of Science ®Google Scholar